COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1
- 15 June 2004
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 119 (2) , 138-142
- https://doi.org/10.1016/j.jss.2004.03.005
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- COX-2 Inhibitors and Other NSAIDs in Bladder and Prostate CancerPublished by S. Karger AG ,2003
- Cyclooxygenase-2: A Therapeutic TargetAnnual Review of Medicine, 2002
- Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.Endocrine-Related Cancer, 2001
- Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cellsPathology, 2001
- Role of Cyclooxygenases in AngiogenesisCurrent Medicinal Chemistry, 2000
- Pure Squamous Cell Carcinoma of the Bladder in Western CountriesEuropean Urology, 2000
- MULTIPLE COMPARISON PROCEDURES UPDATEDClinical and Experimental Pharmacology and Physiology, 1998
- MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION: Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladderCarcinogenesis: Integrative Cancer Research, 1996
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983